Associated tags: Medication, Hospital, Medical device, National Center for Medical Intelligence, Substance-related disorder, KLAS, Health, RFID, Software, Pharmaceutical industry, Pharmacy, Automation
Data Management,
Health,
Technology,
Hospitals,
Practice Management,
Software,
General Health,
Emergency,
Software,
Life,
BCS,
RFID,
Patient,
Patient safety,
Medication,
Hospital,
Check,
Pharmacy,
National Center for Medical Intelligence,
KLAS,
Artificial intelligence,
Multimedia,
Risk,
Safety,
Control,
Crash,
Machine learning,
Substance-related disorder,
Organization,
Medical device,
Online shopping,
Risk management Kit Check today announced that it has rebranded as Bluesight , The Medication Intelligence Company, to reflect its comprehensive suite of software solutions, maintaining its commitment to helping hospitals better serve their patients and pursuing a future where the medication supply chain is more efficient and connected.
Key Points:
- Kit Check today announced that it has rebranded as Bluesight , The Medication Intelligence Company, to reflect its comprehensive suite of software solutions, maintaining its commitment to helping hospitals better serve their patients and pursuing a future where the medication supply chain is more efficient and connected.
- Bluesight provides Medication Intelligence solutions to over 1,000 hospital customers, transforming multiple streams of raw data into actionable insights that empower informed decision-making, offering a data-backed way to navigate every touchpoint of the pharmaceutical supply chain.
- We are thrilled to announce this exciting evolution as we officially rebrand as Bluesight, said Amy Langan, Chief Marketing Officer at Bluesight.
- Through our suite of Medication Intelligence solutions, Bluesight brings simplicity, visibility, and predictability to the complex world of medication management.
Retrieved on:
Thursday, October 13, 2022
News,
National Center for Medical Intelligence,
Becker,
ASHP,
Hospital,
Entrepreneurship,
CEO,
RFID,
Automation,
Medical device,
KLAS ALEXANDRIA, Va., Oct. 13, 2022 /PRNewswire/ -- Kit Check, the leading automation vendor in Medication Intelligence™, today announced it has reached over 1,000 hospital customers across the U.S. through its Medication Intelligence solutions –approximately 25% of the estimated 4,600 acute and children's hospitals in the country.
Key Points:
- Kit Check, the vendor of medication intelligence solutions, reaches 1000 hospital customer milestone.
- Kit Check's newest product, Bluesight Insights, is the latest testament to innovation in the hospital space as well as category-creating technologies.
- To date, Kit Check has partnered with 19 different companies throughout the pharmaceutical supply chain to provide a seamless experience across multiple platforms.
- To date, our more than 1,000 U.S. and Canadian hospital partners have adopted Kit Check solutions to solve the most challenging of healthcare problems.
Human,
KLAS,
Automation,
Software,
CEO,
Controlled substance,
National Center for Medical Intelligence,
Organization,
Research,
Substance-related disorder,
Medical device,
Retail,
Online shopping Kit Check is the market share leader and a top performing vendor in this report, with Kit Check customers consistently seeing success in tangible outcomes.
Key Points:
- Kit Check is the market share leader and a top performing vendor in this report, with Kit Check customers consistently seeing success in tangible outcomes.
- Earlier this year, Kit Check was ranked Best in KLAS for drug diversion monitoring for the third consecutive year.
- In the report, Kit Check's Bluesight for Controlled Substances ranked the highest under the loyalty pillar which gauges customers satisfaction and likelihood of recommending the product to others.
- That is a huge tangible outcome.2"
"When it comes to a diversion monitoring solution, tangible outcomes are always our number one focus."
Hospitals,
Pharmaceutical,
Health,
Death,
Theft,
CEO,
Awareness,
CDC,
Morphine,
Organization,
Solution,
Anesthesiology,
Substance-related disorder,
Patient,
Hospital,
Review,
Health,
Fentanyl,
Industry,
RNS,
Medication,
Doctor of Nursing Practice,
Medicinal plants,
Pharmaceutical industry,
Medical device The Diversion Trends Report revealed that in over 50 million transactions, about 8% or four million were flagged with a potential variance.
Key Points:
- The Diversion Trends Report revealed that in over 50 million transactions, about 8% or four million were flagged with a potential variance.
- However, the report shows that there has been a gradual decrease in the percentage of controlled substance medication transactions that were flagged with a potential variance.
- Other interesting findings from the Diversion Trends Report include:
In Q1 2020, morphine was involved in 12% of all discrepant controlled substance medication transactions.
- The ability to monitor controlled substance transactions for instances of variance plays a huge role in hospitals ability to detect drug diversion, said Kevin MacDonald, CEO and co-founder of Kit Check.
General Health,
Hospitals,
Health,
Pharmaceutical,
Medical Supplies,
Pharmacist,
Summit,
Host,
Solution,
Baxter International,
Â,
Medication,
Association,
Industry,
Panel,
Hospital,
Marketing,
Marketing communications,
VP,
CEO,
National Center for Medical Intelligence,
Pharmacy,
IMI,
Medical device Kit Check, the industry leader in Medication Intelligence solutions for hospitals, today announced that it will be hosting the first annual Medication Intelligence Summit from June 6-8, 2022.
Key Points:
- Kit Check, the industry leader in Medication Intelligence solutions for hospitals, today announced that it will be hosting the first annual Medication Intelligence Summit from June 6-8, 2022.
- The Summit will consist of pharmacist-led sessions, panel discussions of industry trends, and presentations of new product features for Kit Checks suite of Medication Intelligence solutions.
- By hosting this Summit annually, Kit Check hopes to elevate industry leaders knowledge about drug and pharmacy trends to help create a larger network of hospitals and clinicians looking to solve industry pain points and curb drug diversion, said Kevin MacDonald, co-founder and CEO of Kit Check.
- The virtual Summit will be hosted via Zoom and will also be posted on Kit Checks Medication Intelligence Center webpage once it has concluded.
RFID,
Pharmacy,
Organization,
Automation,
Hospital,
Pressure,
Pharmacist,
Technology,
Paola Lattus,
COVID-19,
Canadian Society of Hospital Pharmacists,
Solution,
ICU,
Efficiency,
National Center for Medical Intelligence,
Substance-related disorder,
Pharmaceutical industry,
Healthcare,
Medicine ALEXANDRIA, Va., March 24, 2022 /PRNewswire/ -- Kit Check, the leading automation vendor in Medication Intelligence™ solutions that bring cost savings, efficiency, and patient safety to hospitals, today released the findings of its eighth annual Hospital Pharmacy Operations Report (HPOR), which surveyed 118 hospital pharmacy professionals in the fourth quarter of 2021. This annual survey selectively surveyed a diverse panel of participants of which 89% have worked in the hospital space for over 10+ years. This year, the survey aimed to address current trends still affecting hospital systems related to COVID-19 as well as gain insight on how to offer better solutions to combat these challenges.
Key Points:
- Kit Check's latest Hospital Pharmacy Operations Report highlights trends health systems are experiencing across the US.
- For the fourth consecutive year, over half of pharmacists rank drug shortages as their number one challenge facing pharmacies.
- For context, the percentage of hospital pharmacies experiencing 10 or more drug shortages increased 14% from 2020.
- Without full visibility, pharmacies are more susceptible to drug diversion and less prepared to manage drug shortages.
Economics,
Health care,
MBA,
National Center for Medical Intelligence,
Wharton School of the University of Pennsylvania,
Hospital,
Harvard University,
University,
G100,
Growth,
Efficiency,
BofA Securities,
Health administration,
CEO,
Bank,
Merrill (company),
BA,
Advisory board,
Erica,
The Advisory Board Company,
Management ALEXANDRIA, Va., March 3, 2022 /PRNewswire/ -- Kit Check , the leader in Medication Intelligence solutions that bring cost savings, efficiency, and patient safety to hospitals, today announced the addition of Erica Tingley as Chief Financial Officer.
Key Points:
- ALEXANDRIA, Va., March 3, 2022 /PRNewswire/ -- Kit Check , the leader in Medication Intelligence solutions that bring cost savings, efficiency, and patient safety to hospitals, today announced the addition of Erica Tingley as Chief Financial Officer.
- Ms. Tingley brings over 20 years of experience serving healthcare companies around strategy, finance, and M&A to Kit Check.
- "I am thrilled to welcome Erica to the team and to partner with her as we continue to accelerate growth at Kit Check," said Kevin MacDonald, co-founder & CEO of Kit Check.
- More information about Kit Check and our software solutions can be found at kitcheck.com.
Retrieved on:
Tuesday, February 8, 2022
Policy,
Industry,
Nursing,
Human,
Pharmacy,
National Center for Medical Intelligence,
Solution,
Automation,
Research,
Software,
Data analysis,
Risk,
Efficiency,
Technology,
Hospital,
Patient,
Particle-size distribution,
CEO,
Organization,
Gaps,
Entrepreneurship,
Substance-related disorder,
Pharmaceutical industry,
Audit,
Medical device,
KLAS Solutions like Bluesight for Controlled Substances are more important than ever," said Kevin MacDonald, CEO and Co-Founder of Kit Check.
Key Points:
- Solutions like Bluesight for Controlled Substances are more important than ever," said Kevin MacDonald, CEO and Co-Founder of Kit Check.
- They are at the center of everything we do and are essentially the driving force behind the advancements in the Bluesight for Controlled Substances product.
- KLAS CEO Adam Gale provides some background on the Best in KLAS award.
- Additionally, another director of pharmacy highlighted the industry-leading support and feature collaboration Bluesight for Controlled Substances users can expect from Kit Check.
Retrieved on:
Thursday, January 20, 2022
RFID,
Adoption,
Health,
ASHP,
Growth,
Industry,
SVP,
Substance,
Education,
Hospital,
Medical device,
Pharmaceutical industry,
KLAS The new webinar series will focus on education surrounding the new ASHP Enhancing Adoption of RFID Technology Research Grant.
Key Points:
- The new webinar series will focus on education surrounding the new ASHP Enhancing Adoption of RFID Technology Research Grant.
- Kit Check has always been at the forefront of advancing RFID in healthcare with 600+ hospital customers to date.
- Kit Check will launch a small user group for those interested in the grant to work on ideas for the advancement of RFID in healthcare.
- "Kit Check has always been at the forefront of innovation in healthcare when it comes to RFID.
Retrieved on:
Wednesday, December 8, 2021
Patient safety,
Pain management,
North America,
FSS,
Efficiency,
CEO,
Kit,
Critical care,
Entrepreneurship,
Education,
Radio,
COVID-19,
Radio-frequency identification,
NDC,
Pharmacist,
Bevacizumab,
RFID,
Hospital,
Refrigeration,
Substance-related disorder,
Fagron,
Medical device Medications labeled with RFID tags at the manufacturer level ensures that there is item-level visibility of drug products throughout their dynamic lifecycle.
Key Points:
- Medications labeled with RFID tags at the manufacturer level ensures that there is item-level visibility of drug products throughout their dynamic lifecycle.
- This means better patient safety, optimized inventory for hospitals, cost savings, and dramatically increased workflow simplicity and efficiency.
- "We are so excited to be able to offer RFID-tagged medications for our hospital customers, and even more excited to be working with Fagron to expand the offering of pre-tagged 503B products," said Kevin MacDonald, CEO and Co-Founder of Kit Check.
- More information about Kit Check and our software solutions can be found at kitcheck.com .
